Dr. Ryan M. Weight, D.O.
Hematology & Oncology (Hematology & Oncology Physician)
12605 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 230
Licensed in Colorado since 2018, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
CO license DR.0060664 (first issued 2018; active) · PA license OS016307
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uchealth Highlands Ranch Hospital Highlands Ranch, CO
- Hca-Healthone DBA Swedish Medical Center Englewood, CO
- Centura Health-St Anthony North Health Campus Westminster, CO
- Research Medical Center Kansas City, MO
- HCA Healthone Presbyterian St. Lukes Denver, CO
Medical groups
- Cutaneous Oncology Services LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 230
- Services billed
- 16,153
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 338 | 110 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 236 | 94 |
| New patient office or other outpatient visit, 60-74 minutes | 94 | 94 |
| Established patient office or other outpatient visit, 30-39 minutes | 24 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Aurora, CO | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 31 payments worth $18,367 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $8,174 |
|---|---|
| Immunocore Limited | $5,181 |
| Regeneron Healthcare Solutions, Inc. | $4,775 |
| Iovance Biotherapeutics, Inc. | $77.88 |
| Sun Pharmaceutical Industries Inc. | $41.25 |
| Kyowa Kirin, Inc. | $28.27 |
| Merck Sharp & Dohme LLC | $28.04 |
| Array Biopharma Inc | $27.74 |
| Consulting Fee | $8,140 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $4,615 |
| Honoraria | $3,625 |
| Travel and Lodging | $1,440 |
| Food and Beverage | $547 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Jul 22, 2025 | Consulting Fee | $4,440 |
| E.r. Squibb & Sons, L.l.c. Jul 22, 2025 | Consulting Fee | $3,700 |
| Immunocore Limited Sep 30, 2025 | Honoraria KIMMTRAK · Oncology | $3,625 |
| Regeneron Healthcare Solutions, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) LIBTAYO · ONCOLOGY | $3,377 |
| Immunocore Limited Sep 11, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $742 |
| Regeneron Healthcare Solutions, Inc. Jan 8, 2025 | Compensation for services other than consulting (speaking, faculty) LIBTAYO · ONCOLOGY | $634 |
| Regeneron Healthcare Solutions, Inc. Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) LIBTAYO · ONCOLOGY | $604 |
| Immunocore Limited Sep 11, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $435 |
| Immunocore Limited Sep 13, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $145 |
| Regeneron Healthcare Solutions, Inc. Feb 4, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to COLORADO SPRINGS, CO · in-kind | $92.48 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) LIBTAYO · ONCOLOGY | $604 |
| Immunocore Limited Oct 24, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $25.99 |
| Immunocore Limited Sep 30, 2025 | Honoraria KIMMTRAK · Oncology | $3,625 |
| Immunocore Limited Sep 13, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $145 |
| Immunocore Limited Sep 11, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $742 |
| Immunocore Limited Sep 11, 2025 | Travel and Lodging KIMMTRAK · Oncology · travel to Austin, TX | $435 |
| E.r. Squibb & Sons, L.l.c. Jul 22, 2025 | Consulting Fee | $4,440 |
| E.r. Squibb & Sons, L.l.c. Jul 22, 2025 | Consulting Fee | $3,700 |
| Regeneron Healthcare Solutions, Inc. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) LIBTAYO · ONCOLOGY | $3,377 |
| Regeneron Healthcare Solutions, Inc. Feb 4, 2025 | Travel and Lodging LIBTAYO · ONCOLOGY · travel to COLORADO SPRINGS, CO · in-kind | $92.48 |
| Regeneron Healthcare Solutions, Inc. Jan 8, 2025 | Compensation for services other than consulting (speaking, faculty) LIBTAYO · ONCOLOGY | $634 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 4 companies. The companies reported $1,391,309 in research payments for these studies, mostly to the institutions running them.
- A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT05608291 - An openlabel phase 1 study to investigate PF08046031 in adults with advanced melanoma and other solid tumors
Pfizer Inc. - A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Regeneron Pharmaceuticals, Inc. · Recruiting · NCT06246916 - Study name not reported
Iovance Biotherapeutics, Inc. - A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixeddose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastat…
E.r. Squibb & Sons, L.l.c. - CemiplimAb Survivorship Epidemiology
Regeneron Pharmaceuticals, Inc. · Completed · NCT03836105
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.